Cardinal Health (CAH) Stock Moves -1.47%: What You Should Know

20.03.26 23:00 Uhr

Werte in diesem Artikel
Aktien

181,40 EUR -0,20 EUR -0,11%

Indizes

6.582,7 PKT 7,4 PKT 0,11%

In the latest close session, Cardinal Health (CAH) was down 1.47% at $207.83. The stock exceeded the S&P 500, which registered a loss of 1.51% for the day. Elsewhere, the Dow saw a downswing of 0.97%, while the tech-heavy Nasdaq depreciated by 2.01%. The prescription drug distributor's shares have seen a decrease of 5.32% over the last month, surpassing the Medical sector's loss of 7.54% and falling behind the S&P 500's loss of 3.63%.The investment community will be closely monitoring the performance of Cardinal Health in its forthcoming earnings report. The company is forecasted to report an EPS of $2.8, showcasing a 19.15% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $62.42 billion, up 13.74% from the year-ago period. For the annual period, the Zacks Consensus Estimates anticipate earnings of $10.31 per share and a revenue of $259.27 billion, signifying shifts of +25.12% and +16.48%, respectively, from the last year. It is also important to note the recent changes to analyst estimates for Cardinal Health. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.04% higher within the past month. Cardinal Health is currently a Zacks Rank #2 (Buy). From a valuation perspective, Cardinal Health is currently exchanging hands at a Forward P/E ratio of 20.45. This expresses a premium compared to the average Forward P/E of 15.72 of its industry. Also, we should mention that CAH has a PEG ratio of 1.36. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As the market closed yesterday, the Medical - Dental Supplies industry was having an average PEG ratio of 1.77. The Medical - Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 68, putting it in the top 28% of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions. #1 Semiconductor Stock to Buy (Not NVDA)The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cardinal Health, Inc. (CAH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Cardinal Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Cardinal Health Inc.

Analysen zu Cardinal Health Inc.

DatumRatingAnalyst
08.03.2018Cardinal Health Equal WeightBarclays Capital
04.12.2017Cardinal Health HoldDeutsche Bank AG
19.09.2017Cardinal Health Sector PerformRBC Capital Markets
28.04.2017Cardinal Health NeutralTigress Financial
04.04.2017Cardinal Health HoldNeedham & Company, LLC
DatumRatingAnalyst
03.11.2015Cardinal Health BuyUBS AG
03.11.2015Cardinal Health OutperformFBR Capital
09.06.2015Cardinal Health BuyUBS AG
10.03.2015Cardinal Health OutperformFBR Capital
04.03.2015Cardinal Health OutperformRBC Capital Markets
DatumRatingAnalyst
08.03.2018Cardinal Health Equal WeightBarclays Capital
04.12.2017Cardinal Health HoldDeutsche Bank AG
19.09.2017Cardinal Health Sector PerformRBC Capital Markets
28.04.2017Cardinal Health NeutralTigress Financial
04.04.2017Cardinal Health HoldNeedham & Company, LLC
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cardinal Health Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen